FindTrial
Sign In

Development and application of precision diagnosis and treatment technologies for inflammatory bowel disease

Research and application of precision diagnosis and treatment technologies for inflammatory bowel disease based on multi-omics analysis of Chinese cohorts

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100273
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Healthy control group:None
Inflammatory bowel disease group:None

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with a definitive diagnosis of inflammatory bowel disease

Exclusion criteria

Exclusion criteria: 1.Combined with other autoimmune diseases; 2.no severe coronary heart disease, hypertension, diabetes, active pulmonary tuberculosis, or severe infections.

Design outcomes

Primary

MeasureTime frame
Differential proteins in proteomics;—

Countries

China

Contacts

Public ContactMingsong Li

The Third Affiliated Hospital of Guangzhou Medical University

lims661216@163.com+86 20 81292725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026